Physician profile
Karli Danielle Todd
NPI 1750869913
$1,075.06
in general payments reported to CMS, 2019-2025
12 companies · $733 in 2025
The $733 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $28.79 · 2023: $138 · 2024: $72.21 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734 · Travel and Lodging: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.64 |
| Travel and Lodging | $208.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $663.27 | 2025 | |
| Chiesi USA, INC. | $92.08 | 2021-2023 | Cleviprex, Kengreal |
| La Jolla Pharmaceutical Company | $67.42 | 2024-2025 | Giapreza |
| Atricure, INC. | $64.00 | 2023-2025 | Synergy Ablation System |
| Edwards Lifesciences Corporation | $34.61 | 2023 | Hemosphere |
| Kerecis Limited | $32.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.05 | 2021-2023 | Ofev |
| Silk Road Medical, INC. | $24.47 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $21.17 | 2023 | Uptravi, Opsumit |
| Pfizer INC. | $17.93 | 2021 | |
| Hemosonics LLC | $16.41 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Bard Peripheral Vascular, INC. | $13.95 | 2024 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karli Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.